CHEK2 rs4822983 CC carriers showed a marginally significantly decreased ESCC risk compared with those harboring the CT and TT genotypes in the Jinan population (95% CI = 0.61–1.01, P = 0.064) (Table 3). This evidence concerns the gene CHEK2 and esophageal squamous cell carcinoma.